|
|
Robotic assisted laparoscopic simple suprapubic prostatectomy—The Smith Institute for urology experience with an evolving technique |
Sammy E. Elsamra, Nikhil Gupta, Haris Ahmed, David Leavitt, Jessica Kreshover, Louis Kavoussi, Lee Richstone
|
The Smith Institute for Urology, New Hyde Park, New York, USA |
|
|
Abstract Objective: Despite a multitude of minimally invasive surgical options available for benign prostatic enlargement, open simple prostatectomy (OSP) remains the standard for large prostates (typically greater than 100 g).OSP, however, is associated with significant morbidity.Recently, a few reports touting robotic application to simple prostatectomy have been published.Herein, we reviewed our series of robotic assisted laparoscopic simple suprapubic prostatectomy (RALSSP) and detailed modifications in our technique as our experience increased.Methods: All RALSSP cases performed between January 2013 and January 2014 were reviewed for demographics, pre-operative features, and perioperative outcomes.All parameters were tabulated and mean values were calculated.Student's t-test was utilized with p < 0.05 deemed significant.Details regarding surgical technique were reviewed and highlighted.Results: Fifteen patients underwent RALSSP during this period.Mean age of these men was 69 years.Mean body mass index (BMI) was 28.5 kg/m2.American Society of Anesthesiologists (ASA) score was on average 2.4.Average international prostate symptom score (IPSS) was 16.2 with the majority of men experiencing some adverse clinical sequela of such benign prostatic hyperplasia (BPH).For those patients not in retention, preoperative post-void residual (PVR) was 428 mL.All patients underwent successful RALSSP without need for conversion or need for blood transfusion.Mean estimated blood loss (EBL) was 290 mL.Five patients underwent other concurrent procedures (e.g.cystolithotomy).Mean length of hospital stay (LOS) was 2.4 days and only five patients required continuous bladder irrigation (CBI) postoperatively.Postoperative PVR improved to a mean of 33 mL and IPSS improved to 4.5 (p < 0.001).No major complications were identified.Adaptation of low transverse cystotomy, utilization of a robotic tenaculum in the #3 arm with its control by a surgeon on a second console, and the utilization of mucosal advancement have all subjectively aided in performance of RALSSP and perioperative outcomes.Conclusion: RALSSP allows for feasible performance of prostate adenoma enucleation with low risk of blood transfusion, short LOS, and significant improvement in IPSS and PVR; all while maintaining a minimally invasive approach.The use of a robotic tenaculum controlled by the secondary console and the mucosal advancement facilitate excellent outcomes and may play a role in minimizing hematuria and need for CBI.
|
Received: 15 July 2014
Published: 28 October 2014
|
Corresponding Authors:
Lee Richstone
E-mail: lrichsto@nshs.edu
|
|
|
[1] |
Bhojani N, Gandaglia G, Sood A, Rai A, Pucheril D, Chang SL,et al. Morbidity and mortality after benign prostatic hyperplasiasurgery: data from the american college of surgeons national surgicalquality improvement program. J Endourol 2014; 28: 831-40.
|
[2] |
Health Quality Ontario. Energy delivery systems for treatment ofbenign prostatic hyperplasia: an evidence-based analysis. Ont HealthTechnol Assess Ser 2006; 6: 1-121.
|
[3] |
Pisco JM, Pinheiro LC, Bilhim T, Duarte M, Mendes JR, OliveiraAG. Prostatic arterial embolization to treat benign prostatichyperplasia. J Vasc Interv Radiol 2011; 22: 11-9.
|
[4] |
Suer E, Gokce I, Yaman O, Anafarta K, Gö?ü? O. Openprostatectomy is still a valid option for large prostates: a highvolume,single-center experience. Urology 2008; 72: 90-4.
|
[5] |
Vora A, Mittal S, Hwang J, Bandi G. Robot-assisted simpleprostatectomy: multi-institutional outcomes for glands larger than100 grams. J Endourol 2012; 26: 499-502.
|
[6] |
Weiss BE, Wein AJ, Malkowicz SB, Guzzo TJ. Comparison ofprostate volume measured by transrectal ultrasound and magneticresonance imaging: is transrectal ultrasound suitable to determinewhich patients should undergo active surveillance? Urol Oncol2013; 31: 1436-40.
|
[7] |
Mariano MB, Graziottin TM, Tefilli MV. Laparoscopicprostatectomy with vascular control for benign prostatic hyperplasia.J Urol 2002; 167: 2528-9.
|
[8] |
McCullough TC, Heldwein FL, Soon SJ, Galiano M, BarretE, Cathelineau X, et al. Laparoscopic versus open simpleprostatectomy: an evaluation of morbidity. J Endourol 2009; 23:129-33.
|
[9] |
Sotelo R, Clavijo R, Carmona O, Garcia A, Banda E, Miranda M, etal. Robotic simple prostatectomy. J Urol 2008; 179: 513-5.
|
[10] |
John H, Bucher C, Engel N, Fischer B, Fehr JL. Preperitonealrobotic prostate adenomectomy. Urology 2009; 73: 811-5.
|
[11] |
Uffort EE. Robotic-assisted laparoscopic simple prostatectomy: analternative minimal invasive approach for prostate adenoma. J RobotSurg 2010; 4: 7-10.
|
[12] |
Sutherland DE, Perez DS, Weeks DC. Robot-assisted simpleprostatectomy for severe benign prostatic hyperplasia. J Endourol2011; 25: 641-4.
|
[13] |
Coelho RF, Chauhan S, Sivaraman A, Palmer KJ, Orvieto MA,Rocco B, et al. Modified technique of robotic-assisted simpleprostatectomy: advantages of a vesico-urethral anastomosis. BJU Int2012; 109: 426-33.
|
[14] |
Matei DV, Brescia A, Mazzoleni F, Spinelli M, Musi G, MelegariS, et al. Robot-assisted simple prostatectomy (RASP): does it makesense? BJU Int 2012; 110(11 Pt C): E972-9.
|
[15] |
Leslie S, de Castro Abreu AL, Chopra S, Ramos P, Park D, BergerAK, et al. Transvesical robotic simple prostatectomy: initial clinicalexperience. Eur Urol 2014; pii: S0302-2838(13)01381-X. doi:10.1016/j.eururo.2013.12.020. [Epub ahead of print]
|
[1] |
H.Kim Eric,A.Brockman John,L.Andriole Gerald. The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 28-32. |
[2] |
Xu Peng,Xu Abai,Chen Binshen,Zheng Shaobo,Xu Yawen,Li Hulin,Shen Haiyan,Liu Chunxiao. Bipolar transurethral enucleation and resection of the prostate: Whether it is ready to supersede TURP?[J]. Asian Journal of Urology, 2018, 5(1): 48-54. |
[3] |
Xie Liping,Wang Xiao,Chen Hong,Zheng Xiangyi,Liu Ben,Li Shiqi,Mao Yeqing,Mao Qiqi,Wang Song,Li Jiangfeng,Loch Tillmann. Innovative endoscopic enucleations of the prostate-Xie's Prostate Enucleations[J]. Asian Journal of Urology, 2018, 5(1): 12-16. |
[4] |
Guat Ng Lay. Botulinum toxin and benign prostatic hyperplasia[J]. Asian Journal of Urology, 2018, 5(1): 33-36. |
[5] |
Kok Kit Ng, Foo Cheong Ng. The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men[J]. Asian Journal of Urology, 2017, 4(3): 191-194. |
[6] |
Farhad Fakhrudin Vasanwala, Michael Yuet Chen Wong, Henry Sun Sien Ho, Keong Tatt Foo. Benign prostatic hyperplasia and male lower urinary symptoms:A guide for family physicians[J]. Asian Journal of Urology, 2017, 4(3): 181-184. |
[7] |
Keong Tatt Foo. Pathophysiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 152-157. |
[8] |
Kok Bin Lim. Epidemiology of clinical benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 148-151. |
[9] |
Rikiya Taoka, Yoshiyuki Kakehi. The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia[J]. Asian Journal of Urology, 2017, 4(3): 158-163. |
[10] |
Rajeev Thekumpadam Puthenveetil, Debajit Baishya, Sasanka Barua, Debanga Sarma. Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management[J]. Asian Journal of Urology, 2015, 2(4): 233-237. |
[11] |
Bilal Chughtai, Leanna Laor, Claire Dunphy, Alexis Te. Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia (BPH)[J]. Asian Journal of Urology, 2015, 2(2): 102-106. |
[12] |
Michael E. Chua, Patrick P. Tanseco, Jonathan S. Mendoza, Josefino C. Castillo, Marcelino L. Morales Jr, Saturnino L. Luna Jr. Configuration and validation of a novel prostate disease nomogram predicting prostate biopsy outcome: A prospective study correlating clinical indicators among Filipino adult males with elevated PSA level[J]. Asian Journal of Urology, 2015, 2(2): 114-122. |
|
|
|
|